CRS is an immunotherapy-induced systemic inflammatory syndrome that occurs due to the hyperactivation of the immune system that results in the release of multiple cytokines, including TNFα, IL6, IL10, and IFN. The gene discussed is IL10; the disease is congenital rubella syndrome.